 Carbidopa/levodopa/entacapone

Carbidopa/levodopa/entacapone, sold under the brand name Stalevo, is a dopaminergic combination medication that contains carbidopa, levodopa, and entacapone for the treatment of Parkinson's disease.It is marketed by Swiss-based Novartis Pharmaceuticals and manufactured by Finnish drugmaker Orion Corporation.